Proline derivatives and use thereof as drugs

Details for Australian Patent Application No. 2001277754 (hide)

Owner Mitsubishi Pharma Corporation

Inventors Kitajima, Hiroshi; Akahoshi, Fumihiko; Sakashita, Hiroshi; Hayashi, Yoshiharu

Agent Griffith Hack

Pub. Number AU-B-2001277754

PCT Pub. Number WO02/14271

Priority 2000-243217 10.08.00 JP; 2000-400296 28.12.00 JP

Filing date 10 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 29 September 2005

International Classifications

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/438 - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/506 - not condensed and containing further heterocyclic rings

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 031/401 - Proline

A61P 035/04 Antineoplastic agents

A61K 031/454

A61K 031/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61P 003/10 Drugs for disorders of the metabolism

A61K 031/4439

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 013/08 Drugs for disorders of the urinary system

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61P 001/02 Drugs for disorders of the alimentary tract or the digestive system

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 037/06 Drugs for immunological or allergic disorders

A61K 031/5377

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 017/00 Drugs for dermatological disorders

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 003/04 Drugs for disorders of the metabolism

Event Publications

29 September 2005 Application Accepted

  Published as AU-B-2001277754

2 February 2006 Standard Patent Sealed

14 January 2010 Amendment Made

  The nature of the amendment is: Amend the Patentee name from Mitsubishi Pharma Corporation to Mitsubishi Tanabe Pharma Corporation 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001277755

2001277753